106 GENES FOUND

? »

Limit search: Premium | Premium (Tissue) | Premium (Cell line)

« prev | Page of 3 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

MAP4Microtubule-associated protein 4FDA approved drug targets
Plasma proteins
Expressed in all
MAPK1Mitogen-activated protein kinase 1Cancer-related genes
Cytoskeleton related proteins
Enzymes
FDA approved drug targets
Plasma proteins
RAS pathway related proteins
Expressed in all
MAPK3Mitogen-activated protein kinase 3Cancer-related genes
Cytoskeleton related proteins
Enzymes
FDA approved drug targets
RAS pathway related proteins
Expressed in all
METMet proto-oncogeneCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Mixed
METAP2Methionyl aminopeptidase 2Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
MMP10Matrix metallopeptidase 10 (stromelysin 2)Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enriched
MMP15Matrix metallopeptidase 15 (membrane-inserted)Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Mixed
MTR5-methyltetrahydrofolate-homocysteine methyltransferaseDisease related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Expressed in all
NFKB1Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1Cancer-related genes
FDA approved drug targets
Plasma proteins
RAS pathway related proteins
Transcription factors
Expressed in all
NR3C1Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)Disease related genes
FDA approved drug targets
Nuclear receptors
Plasma proteins
Transcription factors
Expressed in all
PAHPhenylalanine hydroxylaseDisease related genes
Enzymes
FDA approved drug targets
Tissue enhanced
PDE3APhosphodiesterase 3A, cGMP-inhibitedEnzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Tissue enhanced
PDXKPyridoxal (pyridoxine, vitamin B6) kinaseEnzymes
FDA approved drug targets
Plasma proteins
Expressed in all
PLA2G4APhospholipase A2, group IVA (cytosolic, calcium-dependent)Disease related genes
Enzymes
FDA approved drug targets
RAS pathway related proteins
Mixed
POLA1Polymerase (DNA directed), alpha 1, catalytic subunitEnzymes
FDA approved drug targets
Expressed in all
POLEPolymerase (DNA directed), epsilon, catalytic subunitCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
POLE2Polymerase (DNA directed), epsilon 2, accessory subunitEnzymes
FDA approved drug targets
Mixed
PRDX5Peroxiredoxin 5Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Expressed in all
PRKAA1Protein kinase, AMP-activated, alpha 1 catalytic subunitEnzymes
FDA approved drug targets
Expressed in all
PRKAB1Protein kinase, AMP-activated, beta 1 non-catalytic subunitFDA approved drug targets
Expressed in all
PSMB1Proteasome (prosome, macropain) subunit, beta type, 1Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
PSMB10Proteasome (prosome, macropain) subunit, beta type, 10Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
PSMB2Proteasome (prosome, macropain) subunit, beta type, 2Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
PSMB5Proteasome (prosome, macropain) subunit, beta type, 5Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
PSMB9Proteasome (prosome, macropain) subunit, beta type, 9Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
RARARetinoic acid receptor, alphaCancer-related genes
Disease related genes
FDA approved drug targets
Nuclear receptors
Plasma proteins
Transcription factors
Expressed in all
RARBRetinoic acid receptor, betaCancer-related genes
Disease related genes
FDA approved drug targets
Nuclear receptors
Transcription factors
Mixed
RARGRetinoic acid receptor, gammaCancer-related genes
FDA approved drug targets
Nuclear receptors
Plasma proteins
Transcription factors
Expressed in all
RETRet proto-oncogeneCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Tissue enriched
RFKRiboflavin kinaseEnzymes
FDA approved drug targets
Expressed in all
RPL3Ribosomal protein L3FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Ribosomal proteins
Expressed in all
RRM1Ribonucleotide reductase M1Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
RRM2Ribonucleotide reductase M2Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Tissue enhanced
RRM2BRibonucleotide reductase M2 B (TP53 inducible)Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Expressed in all
RXRARetinoid X receptor, alphaCancer-related genes
FDA approved drug targets
Nuclear receptors
Transcription factors
Expressed in all
SCNN1DSodium channel, non-voltage-gated 1, delta subunitFDA approved drug targets
Predicted membrane proteins
Mixed
SHMT1Serine hydroxymethyltransferase 1 (soluble)Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
SIRT5Sirtuin 5FDA approved drug targets
Expressed in all
SMOXSpermine oxidaseEnzymes
FDA approved drug targets
Expressed in all
SMSSpermine synthaseDisease related genes
Enzymes
FDA approved drug targets
Expressed in all
SOAT1Sterol O-acyltransferase 1Enzymes
FDA approved drug targets
Predicted membrane proteins
Tissue enriched
SRCV-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homologCancer-related genes
Cytoskeleton related proteins
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Mixed
SV2ASynaptic vesicle glycoprotein 2AFDA approved drug targets
Predicted membrane proteins
Tissue enriched
TBXAS1Thromboxane A synthase 1 (platelet)Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Mixed
THRAThyroid hormone receptor, alphaCancer-related genes
Disease related genes
FDA approved drug targets
Nuclear receptors
Transcription factors
Expressed in all
TNNC1Troponin C type 1 (slow)Disease related genes
FDA approved drug targets
Plasma proteins
Group enriched
TOP1Topoisomerase (DNA) ICancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Expressed in all
TOP1MTTopoisomerase (DNA) I, mitochondrialEnzymes
FDA approved drug targets
Mitochondrial proteins
Predicted secreted proteins
Expressed in all
TOP2ATopoisomerase (DNA) II alpha 170kDaCancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Tissue enhanced
TOP2BTopoisomerase (DNA) II beta 180kDaEnzymes
FDA approved drug targets
Plasma proteins
Expressed in all

« prev | Page of 3 | next »